AMERICAN SHARED HOSPITAL SERVICES

Listed Company

AMSCIK 0000744825NYSENon-AcceleratedSmaller ReportingServices-Medical LaboratoriesCaliforniaESFY ends Dec 31

Period

FY 2025

Revenue

$28.08M

Net Income

$-1.55M

Total Assets

$55.48M

Equity

$24.03M

Shares Out

6.60M

Op. Cash Flow

$3.10M

Business

AMERICAN SHARED HOSPITAL SERVICES provides turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It offers Gamma Knife radiosurgery, linear accelerator (LINAC) treatments, proton beam radiation therapy (PBRT), equipment leasing and related planning, installation, reimbursement and marketing support, plus direct patient services at company-operated clinics. The company operates through two reportable segments — medical equipment leasing (fee-per-use and revenue sharing contracts) and direct patient services (stand‑alone and joint‑venture treatment centers). Its operations serve medical centers and free‑standing cancer clinics in the United States and in Peru, Ecuador and Mexico.

Summary from filing dated 2025-04-04

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenues	28	28	21	20	18
Maintenance and supplies	3	2	2	2	2
Depreciation and amortization	6	6	5	5	5
Other direct operating costs	14	10	4	4	4
Other direct operating costs, related party	978,000	678,000	851,000	1	759,000
Cost of Revenue	23	19	12	11	11
Gross margin	5	9	9	8	7
Selling and administrative expense	7	7	7	5	5
Interest expense	2	1	1	806,000	739,000
Loss on write down of impaired assets	0	3	940,000	0	—
Operating loss	−4	−3	270,000	2	1
Business Combination, Bargain Purchase, Gain Recognized, Amount	0	4	0	—	—
Interest and other income, net	368,000	248,000	426,000	87,000	−3,000
(Loss) income before income taxes	−3	1	696,000	3	947,000
Income tax benefit	−493,000	−295,000	431,000	963,000	269,000
Net (loss) income	−3	2	265,000	2	678,000
(Plus): net loss attributable to non-controlling interests	1	654,000	345,000	−227,000	−484,000
Net (loss) income attributable to American Shared Hospital Services	−2	2	610,000	1	194,000
(Loss) earnings per common share - basic (in dollars per share)	−0.23	0.34	0.1	0.21	0.03
(Loss) earnings per common share - diluted (in dollars per share)	−0.23	0.33	0.1	0.21	0.03
Weighted average common shares for basic (loss) earnings per share (in shares)	7	6	6	6	6
Weighted average common shares for diluted (loss) earnings per share (in shares)	7	7	6	6	6

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	3	11	14	12	8
Restricted cash	250,000	250,000	118,000	118,000	118,000
Accounts receivable, net of allowance for credit losses of $980,000 and $265,000 at December 31, 2025 and December 31, 2024, respectively	11	12	4	4	4
Tax receivables	978,000	550,000	0	—	—
Other receivables	1	391,000	504,000	327,000	613,000
VAT credits	702,000	112,000	—	—	—
Prepaid maintenance	12,000	1	1	1	1
Prepaid expenses and other current assets	774,000	928,000	526,000	897,000	826,000
Total current assets	18	26	20	19	15
PROPERTY AND EQUIPMENT, net	31	31	26	23	28
LAND	1	19,000	19,000	19,000	19,000
GOODWILL	1	1	1	1	1
INTANGIBLE ASSETS	78,000	78,000	78,000	78,000	78,000
RIGHT OF USE ASSETS, net	4	1	57,000	317,000	654,000
OTHER ASSETS	341,000	437,000	443,000	87,000	73,000
TOTAL ASSETS	55	60	48	44	45
Accounts payable	607,000	2	315,000	230,000	318,000
Employee compensation and benefits	2	1	757,000	735,000	423,000
Other accrued liabilities	2	2	1	2	2
Asset retirement obligations, related party (includes $250,000 and $250,000 non-related party at December 31, 2025 and 2024, respectively)	1	1	650,000	360,000	757,000
Current portion of lease liabilities	150,000	226,000	57,000	292,000	369,000
Current portion of long-term debt, net	17	3	2	1	1
Total current liabilities	23	10	11	5	6
LONG-TERM LEASE LIABILITIES, less current portion	4	2	0	59,000	359,000
LONG-TERM DEBT, net, less current portion	0	17	11	12	14
DEFERRED INCOME TAXES	115,000	924,000	63,000	822,000	478,000
TOTAL LIABILITIES	28	30	22	18	21
COMMITMENTS AND CONTINGENCIES (See Note 10)	—	—	—	—	—
Common stock, no par value (10,000,000 authorized shares; Issued and outstanding shares 6,575,000 at December 31, 2025 and 6,420,000 at December 31, 2024)	11	11	11	11	11
Additional paid-in capital	9	9	8	8	7
Retained earnings	4	6	4	3	2
Total equity- American Shared Hospital Services	24	25	23	22	20
Non-controlling interests in subsidiaries	4	5	4	4	4
Total shareholders equity	28	30	26	26	24
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	55	60	48	44	45

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	6	6	5	5	—
Non cash lease expense	331,000	228,000	−34,000	−40,000	309,000
Accretion of deferred issuance costs	126,000	95,000	46,000	84,000	59,000
Gain on sale of equipment	0	−155,000	0	—	—
Deferred income taxes	−809,000	−359,000	−759,000	344,000	60,000
Accretion of unfavorable lease position	−26,000	−65,000	0	—	—
Stock-based compensation	404,000	373,000	389,000	399,000	420,000
Receivables	−559,000	−7	−719,000	696,000	−519,000
Prepaid expenses and other assets	2	−513,000	21,000	−111,000	14,000
Asset retirement obligations, related party	0	−588,000	0	−397,000	−618,000
Related party liabilities	207,000	324,000	−491,000	−845,000	775,000
Lease liability	−285,000	−228,000	0	—	—
Accounts payable and accrued liabilities	−955,000	2	−79,000	—	—
Income taxes payable	0	−1	974,000	159,000	−230,000
Net cash provided by operating activities	3	167,000	6	7	6
Payment for purchases of property and equipment	−8	−8	−6	−388,000	−2
Cash received in excess of cash paid for RI Acquisition	0	538,000	0	—	0
Proceeds from sale of equipment	0	295,000	0	—	0
Net cash used in investing activities	−8	−7	−6	−388,000	−2
Principal payments on long-term debt	−3	−3	−2	−2	−4
Principal payments on line of credit	−9	−13	−1	0	—
Advances on line of credit	9	11	4	0	—
Long-term debt financing on purchase of property and equipment	0	10	2	0	14
Debt issuance costs long-term debt	0	−164,000	−9,000	−9,000	−325,000
Distributions to non-controlling interests	−21,000	−95,000	0	−573,000	−514,000
Capital contributions from non-controlling interests	8,000	38,000	0	—	—
Net cash (used in) provided by financing activities	−3	4	2	−3	−655,000
Net change in cash and cash equivalents	−8	−3	1	4	4
Cash paid for interest	1	1	1	722,000	680,000
Cash paid for income taxes	739,000	2	297,000	169,000	712,000
Equipment included in accounts payable and accrued liabilities	400,000	990,000	2	0	1
Increase in ARO obligation	0	1	290,000	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro